Offer - Urjas Oil for just ₹ 1 X
Caberlact 0.5 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Acromegaly, Prolactinoma.
Medical history of the patient along with age and gender determines the dosage of Caberlact 0.5 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Caberlact 0.5 Tablet side effects, there are can be others also. These have been listed below. These side effects of Caberlact 0.5 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Caberlact 0.5 Tablet has a Mild effect for pregnant women and Severe effect on lactating mothers. In addition, Caberlact 0.5 Tablet's effects on the liver, heart and kidney are discussed below in the Caberlact 0.5 Tablet related warnings section.
Individuals suffering from medical conditions like High Blood Pressure, Heart Disease, Depression must refrain from the use of Caberlact 0.5 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Caberlact 0.5 Tablet contraindications section.
Besides this, Caberlact 0.5 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Caberlact 0.5 Tablet is considered not safe while driving, and is not addictive.
Caberlact 0.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Caberlact 0.5 Tablet safe for pregnant women?
Caberlact rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Caberlact 0.5 Tablet safe during breastfeeding?
Caberlact may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Caberlact 0.5 Tablet on the Kidneys?
Kidney can be affected by Caberlact. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Caberlact 0.5 Tablet on the Liver?
You may experience side effects on your liver after taking Caberlact. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Caberlact 0.5 Tablet on the Heart?
You may experience side effects on your heart after taking Caberlact. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Caberlact 0.5 Tablet unless your doctor advises you to do so -
Is this Caberlact 0.5 Tablet habit forming or addictive?
No, there is no any evidence that Caberlact 0.5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Caberlact 0.5 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Caberlact 0.5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Caberlact 0.5 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Caberlact 0.5 Tablet
Due to the absence of research, it is difficult to say how Caberlact 0.5 Tablet and food will interact.
Interaction between Alcohol and Caberlact 0.5 Tablet
Taking Caberlact 0.5 Tablet and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)